Buscar
Mostrando ítems 1-10 de 95
Strongly luminescent, highly ionic europium in a lanthanum diphenylphosphinate matrix
(2013-01-01)
A series of insoluble, chemically inert and thermally stable compounds La1-xEux(DPP)3 (x = 0.50, 0.20, 0.10, and 0.050; DPP = diphenylphosphinate) was synthesized and characterized by elemental and thermogravimetric analysis, ...
Strongly luminescent, highly ionic europium in a lanthanum diphenylphosphinate matrix
(2013-01-01)
A series of insoluble, chemically inert and thermally stable compounds La1-xEux(DPP)3 (x = 0.50, 0.20, 0.10, and 0.050; DPP = diphenylphosphinate) was synthesized and characterized by elemental and thermogravimetric analysis, ...
Contrapruebas en el diagnóstico y seguimiento de niños con alergia alimentaria
(Sociedad Médica de Santiago, 2003)
Near-IR emission in Pr(3+)single doped and tunable near-IR emission in Pr3+/Yb3+ codoped tellurite tungstate glasses for broadband optical amplifiers
(Elsevier Science BvAmsterdamHolanda, 2014)
Effects of distance from a heavily transited avenue on asthma and atopy in a periurban shantytown in Lima, Peru
(Elsevier, 2011)
Background: Proximity to roadways increases the risk of asthma in developed countries; however, relatively little is known about this relationship in developing countries, where rapid and uncontrolled growth of cities has ...
Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
(2012-05-05)
Purpose: To assess the safety and efficacy of transitioning patients whose intraocular pressure (IOP) had been insufficiently controlled on prostaglandin analog (PGA) monotherapy to treatment with travoprost 0.004%/timolol ...
Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
(2012-05-05)
Purpose: To assess the safety and efficacy of transitioning patients whose intraocular pressure (IOP) had been insufficiently controlled on prostaglandin analog (PGA) monotherapy to treatment with travoprost 0.004%/timolol ...